STAA שולי רווח נקי ממכירות STAAR Surgical Company

Macroeconomic pressure is dampening demand for vision correction, as clearly demonstrated by the realization margin coefficient; the 0.20 level captures the current state of business profitability. Meanwhile, STAAR Surgical (STAA) dominates the implant niche thanks to patents for a unique material. The EVO ICL technology offers a biocompatible and reversible alternative to laser methods, preserving eye tissue.
פילוחי נתונים אנליטיים מרוכזים עבור STAAR Surgical Co (STAA)

This indicator reflects operational efficiency through the net profit margin, capturing the actual return on every unit of sales. The ability of STAAR Surgical Company (STAA) to absorb costs during the expansion of EVO ICL lenses in the Chinese and US markets directly determines profit dynamics, as clearly evidenced by the net profit margin history.